Event JSON
{
"id": "54dece193bf5e9e55fed746a83d58f43c449ac03f24b345819397e84257d5c7e",
"pubkey": "decf2ae424d7e66f49a8377e573b0fd38e5209f5d895571ab6dc0caf307383ae",
"created_at": 1724712335,
"kind": 1,
"tags": [
[
"t",
"ptsd"
],
[
"t",
"mdma"
],
[
"t",
"maps"
],
[
"t",
"lykos"
],
[
"t",
"health"
],
[
"t",
"science"
],
[
"t",
"psychedelics"
],
[
"proxy",
"https://schleuss.online/users/itnewsbot/statuses/113030747636494214",
"activitypub"
]
],
"content": "More bad news for psychedelic drug company: FDA expands probe after rejection - Enlarge / President of Multidisciplinary Association for Psychedelic S... - https://arstechnica.com/?p=2045406 #psychedelics #science #health #lykos #maps #mdma #ptsd",
"sig": "cb53ff8de3e6ef94bea981f4e7b0961ba6c3dd3746d0dd2a28e9b31d7125f3bd6071475755cb889334e25b0f75312814d75fde38da088d034f7227edd0df66d8"
}
